Clinical research & EBM · Reference
What is a double-blind study?
A double-blind study is a trial in which neither the participants nor the investigators delivering or assessing the intervention know who is in which group. Concealing the allocation in this way reduces performance and detection bias, strengthening confidence in the results.
What blinding prevents
Blinding, also called masking, conceals group allocation to control specific biases. If participants know they are receiving the active intervention, their expectations can change their behaviour and symptom reporting — a source of performance bias. If investigators know the allocation, their assessment of outcomes can drift, consciously or not — a source of detection bias. Double-blinding addresses both at once. It typically depends on a convincing placebo matched to the active intervention so that neither side can tell the groups apart.
Single, double and triple blind
The levels of blinding describe how many parties are kept unaware. In a single-blind study only the participants are blinded. In a double-blind study both the participants and the investigators delivering or assessing the intervention are blinded. In a triple-blind study the data analysts or outcome committee are blinded as well, so that allocation cannot influence the analysis.
Because the terms are used inconsistently in the literature, good reporting describes exactly who was blinded and how, rather than relying on the label alone — a point emphasised by the CONSORT reporting standard.
Blinding within trial design
Blinding works alongside randomisation in a randomized controlled trial: randomisation creates comparable groups at the outset, and blinding keeps them treated and assessed identically thereafter. Some interventions, such as surgery or behavioural programmes, cannot be fully blinded, in which case researchers may at least blind the outcome assessors. When blinding is broken — for example by obvious side effects — investigators report this, because it can reintroduce the biases the design was meant to remove.
Key facts
At a glance
- Definition: Neither participants nor investigators know allocation
- Single-blind: Only participants are blinded
- Double-blind: Participants and investigators blinded
- Triple-blind: Analysts or outcome committee also blinded
- Prevents: Performance bias and detection bias
- Depends on: A convincing matched placebo
Common questions
FAQ
What is the difference between single-blind and double-blind?+
In a single-blind study only the participants are unaware of their group allocation. In a double-blind study both the participants and the investigators delivering or assessing the intervention are unaware, which controls bias from both sides at once.
Why is double-blinding important?+
Double-blinding reduces performance bias from participants changing their behaviour and detection bias from investigators assessing outcomes differently when they know the allocation. Concealing the groups from both sides protects the integrity of the comparison.
Can every study be double-blind?+
No. Some interventions, such as surgery or behavioural programmes, cannot be fully concealed. In those cases researchers often blind the outcome assessors at least, and they report exactly who was blinded so readers can judge the risk of bias.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
